Proliant Health & Biologicals has launched AlbufreeDX, a recombinant human albumin produced through precision fermentation for applications in diagnostics, biopharmaceutical manufacturing, and research. The animal‑origin‑free format is designed to support assay consistency and reduce regulatory complexity. AlbufreeDX provides high purity and lot‑to‑lot reproducibility for uses such as protein stabilization, surface blocking, reagent formulation, and reference standards.
New ProductsResourcesBiopharmaceuticalsDiagnostic techniquesFermentationProteinsRecombinant productProliant Health & BiologicalsAlbufreeDX
